Cargando…
Promoter Methylation of DNA Repair Genes Predicts Disease-free Survival of Gastric Adenocarcinoma after Adjuvant Radiotherapy
The relentless debate on postoperative adjuvant radiotherapy in gastric adenocarcinoma (GA) has been lasting for decades. In this study, a new biomarker, named promoter methylation burden of DNA repair genes (RPMB), was established to identify the subgroup of patients who might benefit from adjuvant...
Autores principales: | An, Ning, Yu, Zhuang, He, Xin-Jia, Zhao, Yuan-Yuan, Yu, Li, Zhang, Yong-Chun, Lu, Hai-Jun, Yang, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334297/ https://www.ncbi.nlm.nih.gov/pubmed/32671186 http://dx.doi.org/10.1016/j.omto.2020.06.006 |
Ejemplares similares
-
Postoperative Adjuvant Radiotherapy for Patients with Gastric Adenocarcinoma
por: Lim, Do Hoon
Publicado: (2012) -
Role of Adjuvant Radiotherapy in Gastric Cancer
por: Yu, Jeong Il
Publicado: (2023) -
Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression
por: Wang, Peng, et al.
Publicado: (2021) -
Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018) -
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
por: Hemmati, Saman Moritz, et al.
Publicado: (2019)